Greenwich Lifesciences (GLSI) P/E Ratio
P/E Ratio as of Jun 13, 2025: -7.28
Average-7.70
Median-7.67
Minimum-8.15
Maximum-7.28
-7.28
Past Month+0.74 (9.23%)
The P/E ratio for Greenwich Lifesciences (GLSI) is -7.28 as of Jun 13, 2025. This represents a decrease of -52.14% compared to its 12-month average P/E ratio of -15.21. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Greenwich Lifesciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Greenwich Lifesciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Greenwich Lifesciences to industry peers.
Greenwich Lifesciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Greenwich Lifesciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Greenwich Lifesciences to industry peers.
Greenwich Lifesciences (GLSI) P/E Ratio Insights
See Greenwich Lifesciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Greenwich Lifesciences (GLSI)
Order type
Buy in
Order amount
Est. shares
0 shares
Greenwich Lifesciences (GLSI) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $9.64 | -7.63 |
| May 1, 2025 | $9.98 | -8.26 |
| Apr 1, 2025 | $9.26 | -11.42 |
| Mar 3, 2025 | $11.70 | -14.42 |
| Feb 3, 2025 | $12.98 | -16.00 |
| Jan 2, 2025 | $11.74 | -14.47 |
Greenwich Lifesciences (GLSI) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -7.28 | -47.44% |
| 2024 | -13.85 | -7.97% |
| 2023 | -15.05 | -43.55% |
| 2022 | -26.66 | -61.42% |
| 2021 | -69.10 | -71.54% |
| 2020 | -242.81 | — |
FAQs About Greenwich Lifesciences (GLSI) P/E ratio
The latest P/E ratio of Greenwich Lifesciences (GLSI) is -7.28, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Greenwich Lifesciences’s last 12-month average P/E ratio is -15.21, compared to its current P/E ratio of -7.28. This reflects a decrease of -52.14%.
Greenwich Lifesciences’s current P/E ratio of -7.28 is lower than its last 12-month average P/E of -15.21. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Greenwich Lifesciences’s average P/E ratio over the last 3 years is -17.53. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Greenwich Lifesciences’s average P/E ratio over the last 5 years is -57.11. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.